Cargando…
Class A G Protein-Coupled Receptor Antagonist Famotidine as a Therapeutic Alternative against SARS-CoV2: An In Silico Analysis
The pandemic associated with Severe Acute Respiratory Syndrome Coronavirus type 2 (SARS-CoV2) and its disease named COVID-19 challenged the scientific community to discover effective therapeutic solutions in a short period. Repurposing existing drugs is one viable approach that emphasizes speed duri...
Autores principales: | Ortega, Joseph T., Serrano, Maria Luisa, Jastrzebska, Beata |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7355875/ https://www.ncbi.nlm.nih.gov/pubmed/32599963 http://dx.doi.org/10.3390/biom10060954 |
Ejemplares similares
-
The Retinoid and Non-Retinoid Ligands of the Rod Visual G Protein-Coupled Receptor
por: Ortega, Joseph T., et al.
Publicado: (2019) -
Omicron SARS-CoV-2 Variant Spike Protein Shows an Increased Affinity to the Human ACE2 Receptor: An In Silico Analysis
por: Ortega, Joseph Thomas, et al.
Publicado: (2021) -
Famotidine Against SARS-CoV2: A Hope or Hype?
por: Ghosh, Ritwik, et al.
Publicado: (2020) -
The in-vitro effect of famotidine on sars-cov-2 proteases and virus replication
por: Loffredo, Madeline, et al.
Publicado: (2021) -
Mutations in the SARS-CoV-2 spike protein modulate the virus affinity to the human ACE2 receptor, an in silico analysis
por: Ortega, Joseph Thomas, et al.
Publicado: (2021)